2025-03-12 |
2025-03-11 |
GV
Geplanter Verkauf
|
Holloway Jean F
SVP, General Counsel
Führungsperson
|
18.020
-8.4%
23,61
425.510 USD
|
18.020
-8.4%
|
23,61
|
425.510 USD
|
|
2025-03-12 |
2025-03-11 |
GV
Geplanter Verkauf
|
Davis John E
Chief Commercial Officer
Führungsperson
|
15.100
-6.7%
23,61
356.549 USD
|
15.100
-6.7%
|
23,61
|
356.549 USD
|
|
2025-03-10 |
2025-03-06 |
V
Verkauf
|
Horton Amy
VP, Chief Accounting Officer
Führungsperson
|
1.048
-0.7%
24,80
25.995 USD
|
1.048
-0.7%
|
24,80
|
25.995 USD
|
|
2025-03-10 |
2025-03-06 |
GV
Geplanter Verkauf
|
Mackin James P
President & CEO
Führungsperson
|
70.700
-7.6%
24,76
1.750.843 USD
|
70.700
-7.6%
|
24,76
|
1.750.843 USD
|
|
2025-03-10 |
2025-03-06 |
V
Verkauf
|
Mackin James P
President & CEO
Führungsperson
|
17.739
-2.0%
24,80
440.005 USD
|
17.739
-2.0%
|
24,80
|
440.005 USD
|
|
2025-03-10 |
2025-03-06 |
V
Verkauf
|
Holloway Jean F
SVP, General Counsel
Führungsperson
|
2.124
-1.1%
24,80
52.685 USD
|
2.124
-1.1%
|
24,80
|
52.685 USD
|
|
2025-03-10 |
2025-03-06 |
V
Verkauf
|
Davis John E
Chief Commercial Officer
Führungsperson
|
2.618
-1.2%
24,80
64.939 USD
|
2.618
-1.2%
|
24,80
|
64.939 USD
|
|
2025-03-10 |
2025-03-06 |
V
Verkauf
|
Stanton Marshall S.
SVP, Clinical & MD Affair
Führungsperson
|
1.603
-1.4%
24,80
39.761 USD
|
1.603
-1.4%
|
24,80
|
39.761 USD
|
|
2025-03-10 |
2025-03-06 |
V
Verkauf
|
Berry Lance A
Executive VP, CFO
Führungsperson
|
4.909
-3.1%
24,80
121.764 USD
|
4.909
-3.1%
|
24,80
|
121.764 USD
|
|
2025-03-06 |
2025-03-05 |
V
Verkauf
|
Holloway Jean F
SVP, General Counsel
Führungsperson
|
472
-0.3%
25,29
11.935 USD
|
472
-0.3%
|
25,29
|
11.935 USD
|
|
2025-03-05 |
2025-03-05 |
K
Kauf
|
SEMEDO ANTHONY B.
Nicht geschäftsführender Verwaltungsratsmitglied
|
600
+inf%
25,25
15.150 USD
|
600
+inf%
|
25,25
|
15.150 USD
|
|
2025-03-05 |
2025-03-05 |
K
Kauf
|
SEMEDO ANTHONY B.
Nicht geschäftsführender Verwaltungsratsmitglied
|
1.500
+4.4%
25,33
37.991 USD
|
1.500
+4.4%
|
25,33
|
37.991 USD
|
|
2025-02-26 |
2025-02-24 |
V
Verkauf
|
Horton Amy
VP, Chief Accounting Officer
Führungsperson
|
485
-0.4%
27,31
13.243 USD
|
485
-0.4%
|
27,31
|
13.243 USD
|
|
2025-02-26 |
2025-02-24 |
V
Verkauf
|
Horton Amy
VP, Chief Accounting Officer
Führungsperson
|
318
-0.2%
27,31
8.683 USD
|
318
-0.2%
|
27,31
|
8.683 USD
|
|
2025-02-26 |
2025-02-24 |
V
Verkauf
|
Horton Amy
VP, Chief Accounting Officer
Führungsperson
|
814
-0.6%
27,31
22.227 USD
|
814
-0.6%
|
27,31
|
22.227 USD
|
|
2025-02-26 |
2025-02-24 |
V
Verkauf
|
Horton Amy
VP, Chief Accounting Officer
Führungsperson
|
1.706
-1.3%
27,31
46.584 USD
|
1.706
-1.3%
|
27,31
|
46.584 USD
|
|
2025-02-26 |
2025-02-24 |
V
Verkauf
|
Mackin James P
President & CEO
Führungsperson
|
4.896
-0.7%
27,31
133.690 USD
|
4.896
-0.7%
|
27,31
|
133.690 USD
|
|
2025-02-26 |
2025-02-24 |
V
Verkauf
|
Mackin James P
President & CEO
Führungsperson
|
6.812
-1.0%
27,31
186.008 USD
|
6.812
-1.0%
|
27,31
|
186.008 USD
|
|
2025-02-26 |
2025-02-24 |
V
Verkauf
|
Mackin James P
President & CEO
Führungsperson
|
13.784
-2.0%
27,31
376.386 USD
|
13.784
-2.0%
|
27,31
|
376.386 USD
|
|
2025-02-26 |
2025-02-24 |
V
Verkauf
|
Mackin James P
President & CEO
Führungsperson
|
16.664
-2.4%
27,31
455.027 USD
|
16.664
-2.4%
|
27,31
|
455.027 USD
|
|
2025-02-26 |
2025-02-24 |
V
Verkauf
|
Berry Lance A
Executive VP, CFO
Führungsperson
|
3.259
-4.1%
27,31
88.990 USD
|
3.259
-4.1%
|
27,31
|
88.990 USD
|
|
2025-02-26 |
2025-02-24 |
V
Verkauf
|
Holloway Jean F
SVP, General Counsel
Führungsperson
|
1.650
-1.1%
27,31
45.055 USD
|
1.650
-1.1%
|
27,31
|
45.055 USD
|
|
2025-02-26 |
2025-02-24 |
V
Verkauf
|
Holloway Jean F
SVP, General Counsel
Führungsperson
|
810
-0.5%
27,31
22.118 USD
|
810
-0.5%
|
27,31
|
22.118 USD
|
|
2025-02-26 |
2025-02-24 |
V
Verkauf
|
Holloway Jean F
SVP, General Counsel
Führungsperson
|
490
-0.3%
27,31
13.380 USD
|
490
-0.3%
|
27,31
|
13.380 USD
|
|
2025-02-26 |
2025-02-24 |
V
Verkauf
|
Holloway Jean F
SVP, General Counsel
Führungsperson
|
2.385
-1.5%
27,31
65.125 USD
|
2.385
-1.5%
|
27,31
|
65.125 USD
|
|
2025-02-26 |
2025-02-24 |
V
Verkauf
|
Davis John E
Chief Commercial Officer
Führungsperson
|
2.035
-1.3%
27,31
55.568 USD
|
2.035
-1.3%
|
27,31
|
55.568 USD
|
|
2025-02-26 |
2025-02-24 |
V
Verkauf
|
Davis John E
Chief Commercial Officer
Führungsperson
|
985
-0.6%
27,31
26.896 USD
|
985
-0.6%
|
27,31
|
26.896 USD
|
|
2025-02-26 |
2025-02-24 |
V
Verkauf
|
Davis John E
Chief Commercial Officer
Führungsperson
|
591
-0.4%
27,31
16.138 USD
|
591
-0.4%
|
27,31
|
16.138 USD
|
|
2025-02-26 |
2025-02-24 |
V
Verkauf
|
Davis John E
Chief Commercial Officer
Führungsperson
|
2.846
-1.7%
27,31
77.713 USD
|
2.846
-1.7%
|
27,31
|
77.713 USD
|
|
2025-02-26 |
2025-02-24 |
V
Verkauf
|
Stanton Marshall S.
SVP, Clinical & MD Affair
Führungsperson
|
1.246
-1.5%
27,31
34.023 USD
|
1.246
-1.5%
|
27,31
|
34.023 USD
|
|
2025-02-26 |
2025-02-24 |
V
Verkauf
|
Stanton Marshall S.
SVP, Clinical & MD Affair
Führungsperson
|
672
-0.8%
27,31
18.350 USD
|
672
-0.8%
|
27,31
|
18.350 USD
|
|
2025-02-26 |
2025-02-24 |
V
Verkauf
|
Stanton Marshall S.
SVP, Clinical & MD Affair
Führungsperson
|
470
-0.6%
27,31
12.834 USD
|
470
-0.6%
|
27,31
|
12.834 USD
|
|
2025-02-26 |
2025-02-24 |
V
Verkauf
|
Stanton Marshall S.
SVP, Clinical & MD Affair
Führungsperson
|
2.299
-2.7%
27,31
62.776 USD
|
2.299
-2.7%
|
27,31
|
62.776 USD
|
|
2024-12-12 |
2024-12-11 |
V
Verkauf
|
Holloway Jean F
SVP, General Counsel
Führungsperson
|
4.035
-2.6%
30,00
121.050 USD
|
4.035
-2.6%
|
30,00
|
121.050 USD
|
|
2024-12-12 |
2024-12-11 |
V
Verkauf
|
Holloway Jean F
SVP, General Counsel
Führungsperson
|
4.035
-2.5%
30,25
122.059 USD
|
4.035
-2.5%
|
30,25
|
122.059 USD
|
|
2024-12-09 |
2024-12-06 |
V
Verkauf
|
Horton Amy
VP, Chief Accounting Officer
Führungsperson
|
4.329
-3.1%
29,66
128.398 USD
|
4.329
-3.1%
|
29,66
|
128.398 USD
|
|
2024-12-04 |
2024-12-04 |
GV
Geplanter Verkauf
|
GREEN ANDREW M
VP Regulatory
Führungsperson
|
7.618
-18.5%
30,00
228.540 USD
|
7.618
-18.5%
|
30,00
|
228.540 USD
|
|
2024-10-02 |
2024-10-01 |
GV
Geplanter Verkauf
|
Horton Amy
VP, Chief Accounting Officer
Führungsperson
|
12.430
-8.2%
26,18
325.415 USD
|
12.430
-8.2%
|
26,18
|
325.415 USD
|
|
2024-08-27 |
2024-08-26 |
V
Verkauf
|
Holloway Jean F
SVP, General Counsel
Führungsperson
|
3.167
-1.9%
26,55
84.096 USD
|
3.167
-1.9%
|
26,55
|
84.096 USD
|
|
2024-08-19 |
2024-08-16 |
V
Verkauf
|
Getz Matthew A
VP, Human Resources
Führungsperson
|
2.562
-7.0%
25,31
64.848 USD
|
2.562
-7.0%
|
25,31
|
64.848 USD
|
|
2024-08-19 |
2024-08-16 |
V
Verkauf
|
Getz Matthew A
VP, Human Resources
Führungsperson
|
6.858
-15.8%
25,31
173.586 USD
|
6.858
-15.8%
|
25,31
|
173.586 USD
|
|
2024-08-16 |
2024-08-15 |
V
Verkauf
|
Holloway Jean F
SVP, General Counsel
Führungsperson
|
2.383
-1.4%
25,76
61.393 USD
|
2.383
-1.4%
|
25,76
|
61.393 USD
|
|
2024-08-15 |
2024-08-13 |
V
Verkauf
|
SEMEDO ANTHONY B.
Nicht geschäftsführender Verwaltungsratsmitglied
|
9.709
-22.1%
24,99
242.628 USD
|
9.709
-22.1%
|
24,99
|
242.628 USD
|
|
2024-05-13 |
2024-05-10 |
V
Verkauf
|
Holloway Jean F
SVP, General Counsel
Führungsperson
|
1.250
-0.7%
23,42
29.275 USD
|
1.250
-0.7%
|
23,42
|
29.275 USD
|
|
2024-05-10 |
2024-05-09 |
V
Verkauf
|
Holloway Jean F
SVP, General Counsel
Führungsperson
|
979
-0.6%
23,79
23.286 USD
|
979
-0.6%
|
23,79
|
23.286 USD
|
|
2024-05-10 |
2024-05-09 |
V
Verkauf
|
Holloway Jean F
SVP, General Counsel
Führungsperson
|
979
-0.6%
23,79
23.286 USD
|
979
-0.6%
|
23,79
|
23.286 USD
|
|
2024-03-21 |
2024-03-20 |
V
Verkauf
|
Stanton Marshall S.
SVP, Clinical & MD Affair
Führungsperson
|
2.183
-2.6%
20,39
44.511 USD
|
2.183
-2.6%
|
20,39
|
44.511 USD
|
|
2024-03-18 |
2024-03-15 |
GV
Geplanter Verkauf
|
GREEN ANDREW M
VP Regulatory
Führungsperson
|
1.462
-3.4%
20,00
29.240 USD
|
1.462
-3.4%
|
20,00
|
29.240 USD
|
|
2024-03-15 |
2024-03-14 |
GV
Geplanter Verkauf
|
GREEN ANDREW M
VP Regulatory
Führungsperson
|
3.994
-8.6%
20,00
79.880 USD
|
3.994
-8.6%
|
20,00
|
79.880 USD
|
|
2024-03-14 |
2024-03-12 |
V
Verkauf
|
Getz Matthew A
VP, Human Resources
Führungsperson
|
5.000
-10.3%
19,94
99.720 USD
|
5.000
-10.3%
|
19,94
|
99.720 USD
|
|
2024-03-07 |
2024-03-05 |
V
Verkauf
|
Getz Matthew A
VP, Human Resources
Führungsperson
|
1.157
-2.3%
18,72
21.661 USD
|
1.157
-2.3%
|
18,72
|
21.661 USD
|
|
2024-03-07 |
2024-03-05 |
V
Verkauf
|
Maney Rochelle L.
VP, Quality
Führungsperson
|
1.157
-2.4%
18,72
21.662 USD
|
1.157
-2.4%
|
18,72
|
21.662 USD
|
|
2024-03-07 |
2024-03-05 |
V
Verkauf
|
Stanton Marshall S.
SVP, Clinical & MD Affair
Führungsperson
|
1.506
-1.7%
18,72
28.195 USD
|
1.506
-1.7%
|
18,72
|
28.195 USD
|
|
2024-03-07 |
2024-03-05 |
V
Verkauf
|
Holloway Jean F
SVP, General Counsel
Führungsperson
|
2.380
-1.4%
18,72
44.559 USD
|
2.380
-1.4%
|
18,72
|
44.559 USD
|
|
2024-03-07 |
2024-03-05 |
V
Verkauf
|
Mackin James P
President & CEO
Führungsperson
|
13.996
-1.9%
18,72
262.037 USD
|
13.996
-1.9%
|
18,72
|
262.037 USD
|
|
2024-03-07 |
2024-03-05 |
V
Verkauf
|
Davis John E
Chief Commercial Officer
Führungsperson
|
2.022
-1.2%
18,72
37.856 USD
|
2.022
-1.2%
|
18,72
|
37.856 USD
|
|
2024-03-07 |
2024-03-05 |
V
Verkauf
|
Horton Amy
VP, Chief Accounting Officer
Führungsperson
|
1.152
-0.8%
18,72
21.568 USD
|
1.152
-0.8%
|
18,72
|
21.568 USD
|
|
2024-03-07 |
2024-03-05 |
V
Verkauf
|
GREEN ANDREW M
VP Regulatory
Führungsperson
|
1.160
-2.4%
18,72
21.718 USD
|
1.160
-2.4%
|
18,72
|
21.718 USD
|
|
2024-02-29 |
2024-02-27 |
V
Verkauf
|
Stanton Marshall S.
SVP, Clinical & MD Affair
Führungsperson
|
465
-0.6%
19,83
9.223 USD
|
465
-0.6%
|
19,83
|
9.223 USD
|
|
2024-02-29 |
2024-02-27 |
V
Verkauf
|
Horton Amy
VP, Chief Accounting Officer
Führungsperson
|
325
-0.2%
19,83
6.446 USD
|
325
-0.2%
|
19,83
|
6.446 USD
|
|
2024-02-29 |
2024-02-27 |
V
Verkauf
|
Holloway Jean F
SVP, General Counsel
Führungsperson
|
485
-0.3%
19,83
9.620 USD
|
485
-0.3%
|
19,83
|
9.620 USD
|
|
2024-02-29 |
2024-02-27 |
V
Verkauf
|
Tyrs Florian
VP, Global Operations
Führungsperson
|
339
-1.5%
19,83
6.724 USD
|
339
-1.5%
|
19,83
|
6.724 USD
|
|
2024-02-29 |
2024-02-27 |
V
Verkauf
|
Mackin James P
President & CEO
Führungsperson
|
4.837
-0.7%
19,83
95.939 USD
|
4.837
-0.7%
|
19,83
|
95.939 USD
|
|
2024-02-29 |
2024-02-27 |
V
Verkauf
|
Getz Matthew A
VP, Human Resources
Führungsperson
|
325
-0.7%
19,83
6.446 USD
|
325
-0.7%
|
19,83
|
6.446 USD
|
|
2024-02-29 |
2024-02-27 |
V
Verkauf
|
Maney Rochelle L.
VP, Quality
Führungsperson
|
370
-0.8%
19,83
7.339 USD
|
370
-0.8%
|
19,83
|
7.339 USD
|
|
2024-02-29 |
2024-02-27 |
V
Verkauf
|
Davis John E
Chief Commercial Officer
Führungsperson
|
584
-0.4%
19,83
11.583 USD
|
584
-0.4%
|
19,83
|
11.583 USD
|
|
2024-02-29 |
2024-02-27 |
V
Verkauf
|
GREEN ANDREW M
VP Regulatory
Führungsperson
|
421
-0.9%
19,83
8.350 USD
|
421
-0.9%
|
19,83
|
8.350 USD
|
|
2024-02-28 |
2024-02-26 |
V
Verkauf
|
Stanton Marshall S.
SVP, Clinical & MD Affair
Führungsperson
|
1.448
-1.7%
20,27
29.353 USD
|
1.448
-1.7%
|
20,27
|
29.353 USD
|
|
2024-02-28 |
2024-02-26 |
V
Verkauf
|
Stanton Marshall S.
SVP, Clinical & MD Affair
Führungsperson
|
1.600
-2.2%
20,27
32.434 USD
|
1.600
-2.2%
|
20,27
|
32.434 USD
|
|
2024-02-28 |
2024-02-26 |
V
Verkauf
|
GREEN ANDREW M
VP Regulatory
Führungsperson
|
1.218
-2.7%
20,27
24.690 USD
|
1.218
-2.7%
|
20,27
|
24.690 USD
|
|
2024-02-28 |
2024-02-26 |
V
Verkauf
|
GREEN ANDREW M
VP Regulatory
Führungsperson
|
1.185
-3.0%
20,27
24.021 USD
|
1.185
-3.0%
|
20,27
|
24.021 USD
|
|
2024-02-28 |
2024-02-26 |
V
Verkauf
|
Maney Rochelle L.
VP, Quality
Führungsperson
|
1.130
-2.5%
20,27
22.906 USD
|
1.130
-2.5%
|
20,27
|
22.906 USD
|
|
2024-02-28 |
2024-02-26 |
V
Verkauf
|
Maney Rochelle L.
VP, Quality
Führungsperson
|
1.185
-2.9%
20,27
24.021 USD
|
1.185
-2.9%
|
20,27
|
24.021 USD
|
|
2024-02-28 |
2024-02-26 |
V
Verkauf
|
Mackin James P
President & CEO
Führungsperson
|
13.168
-1.9%
20,27
266.930 USD
|
13.168
-1.9%
|
20,27
|
266.930 USD
|
|
2024-02-28 |
2024-02-26 |
V
Verkauf
|
Mackin James P
President & CEO
Führungsperson
|
18.144
-2.7%
20,27
367.799 USD
|
18.144
-2.7%
|
20,27
|
367.799 USD
|
|